Acute respiratory distress syndrome (ARDS) is present in >10% of all people admitted to critical care and is associated with severe morbidity and mortality. Despite more than half a century since its ...

In conclusion, the findings of this study provide evidence that glucocorticoid treatment-induced down-regulation of systemic inflammation in ARDS is associated with a significant improvement in ...

ARDS treatment includes supplemental oxygen and mechanical ventilation. The goal is to get more oxygen into the bloodstream since the lungs can't. When this treatment doesn't work, the lungs are ...

The approval is for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome or ARDS who are receiving systemic corticosteroids as part of standard care and ...

Healios KK (JP:4593) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly ...

In a groundbreaking study led by Dr. Ying Chen and her team from Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, researchers have uncovered a novel mechanism behind endothelial ...

While additional therapies are emerging, because of its unique mechanism of action, ARDS-003 is not expected to induce side-effects commonly associated with other inflammatory treatments including ...

The lack of a clear concept challenges the general practitioner's decision-making when a diagnosis or a treatment approach must be selected for a patient with a functional disorder. This calls for ...

About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug ...

other treatments with varying levels of intensity ... IC also showed a higher probability of positive absolute risk differences (ARDs) in abstinence at 3 months vs. QL and QL+ with 99% and 98% ...